CONNECT WITH US
HealthTech

HealthTech

STAT+: As more doctors consult chatbots, health systems can block them — or buy in

STAT — Health Tech logo

Published on

Add as a preferred source on Google
STAT+: As more doctors consult chatbots, health systems can block them — or buy in

Earlier this year, Patrick Woodard had to have a talk with one of the hundreds of clinicians that work at Monument Health, where he is chief information officer. The South Dakota and Wyoming-based health system had decided to block access to OpenEvidence, the popular free artificial intelligence tool, and Woodard had gotten a few objections. 

One of them, Woodard recounted, was from a super user. This doctor was storing more than a hundred patient records inside OpenEvidence, and feeding them to the artificial intelligence tool for help making medical decisions. That would have to end, Woodard told him.

In the last year, free chatbots built to answer clinician questions — including OpenEvidence, Doximity Ask, and ChatGPT for Clinicians — have grown in popularity. Hundreds of thousands of doctors use the tools, in part, because they claim to be compliant with the federal health data privacy law HIPAA, allowing users to share a patient’s protected health information directly with the AI after signing an agreement. That assurance is meant to address one potential risk of the technology, while making it more valuable day-to-day. 



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.